2023
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome
Yu Y, Zhang M, Mukherjee B. An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome. Statistics In Medicine 2023, 42: 3699-3715. PMID: 37392070, DOI: 10.1002/sim.9826.Peer-Reviewed Original ResearchMeSH KeywordsComputer SimulationHumansMaleModels, StatisticalProbabilityPropensity ScoreProstatic NeoplasmsRegression AnalysisTreatment OutcomeConceptsRight censoringWeighted score functionCausal treatment effectsAverage treatment effectAsymptotic propertiesCensored componentPre-specified time windowEstimation consistencyRobustness propertiesSimulation studyBinary outcomesPresence of confoundersCensoringScoring functionInverse probabilityTreatment effectsEstimationSources of biasInferenceLetter CComparative effectiveness researchTreatment switchRegression methodLogistic regression modelsInsurance claims database
2016
Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis
Koi M, Garcia M, Choi C, Kim H, Koike J, Hemmi H, Nagasaka T, Okugawa Y, Toiyama Y, Kitajima T, Imaoka H, Kusunoki M, Chen Y, Mukherjee B, Boland C, Carethers J. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis. Gastroenterology 2016, 150: 944-955. PMID: 26752111, PMCID: PMC4808397, DOI: 10.1053/j.gastro.2015.12.032.Peer-Reviewed Original ResearchMeSH KeywordsBiomarkers, TumorChi-Square DistributionChromosome AberrationsChromosomes, Human, Pair 9Colorectal NeoplasmsDisease ProgressionDisease-Free SurvivalFemaleGenetic Predisposition to DiseaseHumansJapanKaplan-Meier EstimateLiver NeoplasmsLogistic ModelsLoss of HeterozygosityMaleMicrosatellite RepeatsMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingOdds RatioPhenotypeProportional Hazards ModelsProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Republic of KoreaRisk FactorsTime FactorsTreatment OutcomeConceptsPrimary colorectal tumorsLoss of heterozygosityLiver metastasesColorectal cancerColorectal tumorsElevated microsatellite alterationsMicrosatellite alterationsStage IICurative treatment of patientsStage III colorectal cancerOverall survival of patientsSurvival of patientsIII colorectal cancerTumor to liverColorectal cancer recurrenceTreatment of patientsMatched liver metastasesCancer cell nucleiMatched metastasesDisease recurrenceOverall survivalPrognostic factorsAllelic lossNo significant differenceCurative treatment